Navigation Links
Transcept Pharmaceuticals to Present at RBC Capital Markets 2007 Healthcare Conference
Date:12/7/2007

PT. RICHMOND, Calif., Dec. 7 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President & Chief Executive Officer, will participate in an expert panel on "Drug Development in a Changed Environment" at the RBC Capital Markets 2007 Healthcare Conference at the Westin New York Hotel at Times Square on Thursday, December 13, 2007 at 10:00 AM Eastern Time.

The multi-company panel will be moderated by Ken Trbovich, Vice President, Capital Markets at RBC, and will be available at the following link via webcast: http://www.wsw.com/webcast/rbc84/panel24.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company deriving significant new patient benefits from proven CNS drugs. Transcept development projects leverage new understanding of CNS conditions to provide additional uses and enhanced clinical benefits for existing active agents. The lead Transcept product, Intermezzo(R) (zolpidem tartrate lozenge), is a low dose sublingual formulation of zolpidem that is currently in late phase 3 clinical trials for the treatment of insomnia in patients who awaken in the middle of the night and have difficulty returning to sleep. Another product being developed by Transcept is TO-2060, a novel, fixed-dose combination of olanzapine and ondansetron for the treatment of dopamine associated psychiatric disorders. TO-2060 is currently the subject of an initial proof of concept trial in the treatment of alcohol use disorder. For more information, please visit the company's website at: http://www.transcept.com.

Contacts:

Transcept Pharmaceuticals, Inc. The Ruth Group

Michael Gill Investors / Media

Director of Communications Stephanie Carrington / Jason Rando

(510) 215-3575 (646) 536-7017 / 7025

mgill@transcept.com scarrington@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Transcept Pharmaceuticals to Present at 19th Annual Piper Jaffray Health Care Conference
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced a ... By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization part ... of a needle stick and more importantly, helps our staff members locate a vein ...
(Date:8/16/2017)... YORK, NY (PRWEB) , ... August 16, 2017 , ... ... for better treatments and ultimately, a cure. , The grants are awarded through ... comprised of scientists with a wide array of backgrounds and expertise in all areas ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... 9781498499613; $5.99, eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, ... Strawn of God's love, and all the many ways God shows love to ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... to patients suffering from chronic pelvic pain. In addition to oncology services, ... pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during menstruation), uterine fibroids, and ...
(Date:8/16/2017)... West Orange, NJ (PRWEB) , ... August 16, 2017 , ... With low back pain ... not even know what causes its kissing cousin – upper back pain. But this equally ... bevy of treatment options, according to Kaixuan Liu, MD, PhD , founder and president ...
Breaking Medicine News(10 mins):
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
(Date:7/24/2017)... , July 24, 2017 IBM (NYSE: ... Gartner Magic Quadrant for Solid-State Arrays (SSA) for the fourth ... According to Gartner, "Vendors in the Leaders quadrant ... Completeness of Vision. A vendor in the Leaders quadrant has ... to drive the acceptance of new technologies. These vendors demonstrate ...
(Date:7/21/2017)... EDMONTON, Alberta , July 21, 2017 ... the University of Alberta in Edmonton, ... Nature,s partner journal, Schizophrenia 1 , demonstrating that ... of schizophrenia with 74% accuracy. This retrospective analysis ... specific symptoms in schizophrenia patients with significant correlation, ...
Breaking Medicine Technology: